Candida auris (C. auris) poses a serious global health threat due to its drug resistance, ability to persist on surfaces, and high mortality rates in infected patients. AvantGuard is tackling this challenge head-on with Avantamine™, a revolutionary chlorine-based compound inspired by the human immune system.
Unlike traditional treatments, Avantamine™ offers a three-pronged solution: a powerful liquid antiseptic wash, a long-lasting antifungal ointment, and a residual disinfectant for surfaces. This cutting-edge approach not only targets C. auris but also prevents its re-colonization on skin and surfaces, breaking the infection cycle.
Want to learn more about how AvantGuard is leading the fight against this urgent health threat? You can read the full article on Innovation News Network by clicking button below, or download it as a PDF!